Arrowhead Pharmaceuticals (ARWR) Earnings Date
The next earnings date for Arrowhead Pharmaceuticals (ARWR) is expected by Nov 30, 2026, per the data provider's calendar.
- Next earnings date
- Nov 30, 2026
- expected by
- Latest stored quarter
- EPS −3.04
- revenue $37.8M · reported Nov 12, 2026
Does this company deliver against its own promises? Earnings are a check on the thesis, not a catalyst to chase.
0 of 2 scored quarters beat.
| Report | Est EPS | Act EPS | Surprise | Est rev | Act rev | Rev surp. | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 12, 20268-K, after close · 4:01 pm ET | −1.52 | −3.04 | −100.3% | $61.2M | $37.8M | −38.2% | +1.3%next session |
| Aug 4, 2026 filed | −1.28 | −1.36 | −6.5% | $44.2M | $75.3M | +70.4% | —filing date only |
| May 7, 20268-K, after close · 4:02 pm ET | — | −0.93 | — | — | $73.7M | — | −6.7%next session |
| Aug 7, 20258-K, after close · 4:07 pm ET | — | −1.26 | — | — | $27.8M | — | +2.2%next session |
| Feb 10, 20258-K, after close · 4:03 pm ET | — | −1.39 | — | — | $2.5M | — | −5.2%next session |
| Nov 26, 20248-K, after close · 4:19 pm ET | — | −1.36 | — | — | $3.6M | — | +24.2%next session |
| Aug 8, 20248-K, after close · 4:04 pm ET | — | −1.38 | — | — | $0.00 | — | −9.4%next session |
| May 9, 20248-K, after close · 4:11 pm ET | — | −1.02 | — | — | $0.00 | — | −10.7%next session |
Estimate-vs-actual scoring began Jul 2026 and is still accruing: 2 of the 8 quarters above carry a scored estimate. We never backfill an estimate we didn't observe.
filed marks a quarter where we found no results release and hold only the date its report was filed. A filing can trail the release by days or weeks, so those rows show no reaction rather than the move of an unrelated session.
| Measure | Dec '26 | Mar '27 | FY27 | FY28 |
|---|---|---|---|---|
| No. of analysts | 5 | 4 | 11 | 8 |
| Avg estimate | −1.46 | −1.38 | −5.36 | −3.68 |
| Low estimate | −1.68 | −1.77 | −7.46 | −5.76 |
| High estimate | −1.18 | −0.94 | −2.83 | 0.17 |
| Year-ago EPS | — | −0.93 | −5.11 | −5.36E |
| Implied growth | — | — | — | — |
| Measure | Dec '26 | Mar '27 | FY27 | FY28 |
|---|---|---|---|---|
| No. of analysts | 4 | 4 | 10 | 9 |
| Avg estimate | $45.0M | $59.9M | $306.3M | $552.2M |
| Low estimate | $21.7M | $31.0M | $127.4M | $269.8M |
| High estimate | $65.0M | $115.1M | $536.5M | $835.0M |
| Year-ago revenue | — | $73.7M | $450.8M | $306.3ME |
| Implied growth | — | −18.8% | −32.1% | +80.3% |
| Snapshot age | Dec '26, period ending Dec 30, 2026 | Mar '27, period ending Mar 30, 2027 | FY27, period ending Sep 30, 2027 | FY28, period ending Sep 30, 2028 |
|---|---|---|---|---|
| Current estimate | −1.46 | −1.38 | −5.36 | −3.68 |
| 7 days ago | −1.37 | — | −4.86 | — |
| 30 days ago | −1.37 | — | −4.86 | — |
| 60 days ago | −1.34 | — | −4.66 | — |
| 90 days ago | −1.41 | — | −4.72 | — |
Estimate history accrues from our nightly snapshots. The 7/30/60/90-day rows fill in as tracking continues. Each column follows one fiscal period back through our snapshots; a dash means we had not recorded that period at that age. A rising bar makes a beat streak more meaningful; a falling one manufactures beats.
Dec '26 quarter consensus moved $−1.41 → $−1.46 over 90 tracked days, the same quarter at both ends. Per-analyst up/down revision counts aren't in our data feed. We show the bar's actual movement instead of guessing.
Common questions
When does Arrowhead Pharmaceuticals report earnings next?
Arrowhead Pharmaceuticals' next earnings date is expected by Nov 30, 2026, per the data provider's calendar.
What were Arrowhead Pharmaceuticals' latest quarterly earnings?
Arrowhead Pharmaceuticals reported diluted EPS of −3.04 and revenue of $37.8M on Nov 12, 2026.
How did Arrowhead Pharmaceuticals' stock move after its last earnings report?
Arrowhead Pharmaceuticals moved +1.3% in the session after its Nov 12, 2026 report.

